Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension

Hypertension. 2025 Dec 9. doi: 10.1161/HYPERTENSIONAHA.125.25563. Online ahead of print.ABSTRACTBACKGROUND: Hypertension is a cause and consequence of chronic kidney disease (CKD). Resistant hypertension is common and often difficult to control in patients with CKD. This post hoc analysis evaluated

P Patrick Rossignol

Cereal beta-glucan and cardiovascular disease risk reduction in overweight and obese populations: a systematic review and meta-analysis of lipid, blood pressure, and anthropometric parameters

Food Funct. 2025 Dec 9. doi: 10.1039/d5fo03598h. Online ahead of print.ABSTRACTObesity-related dyslipidemia and hypertension are the key drivers of global cardiovascular disease (CVD) mortality. Although the lipid-lowering capacity of beta-glucan has been demonstrated in the general population, evid

R Ruihao Zheng

Features of arterial hypertension in individuals with anxiety disorders

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(11):44-51. doi: 10.17116/jnevro202512511144.ABSTRACTOBJECTIVE: Identification of differential diagnostic criteria of arterial hypertension (AH) as a manifestation of an independent disease and AH as a manifestation of anxiety disorders (AD), as well as

M M A Gastasheva

Treatment of heart failure in Sweden: progress but not there yet

Lakartidningen. 2025 Dec 9;122:25032.ABSTRACTA growing number of pharmacological and device-based therapies are available to improve well-being and prognosis for patients with heart failure. The increasing complexity of the treatment algorithm also makes implementation of optimal therapy challenging

F Felix Lindberg

Nonsystemic Vasculitic Neuropathy-A Brazilian Case Series

J Peripher Nerv Syst. 2025 Dec;30(4):e70086. doi: 10.1111/jns.70086.ABSTRACTBACKGROUND AND AIMS: Vasculitides are a heterogeneous group of immune-mediated inflammatory disorders that compromise the vascuar wall, leading to luminal narrowing and tissue ischemia. When inflammation selectively affects

V Victor Evangelista Rodrigues Pereira

Cardiovascular effects of intra-abdominal hypertension: current perspectives

Anaesthesiol Intensive Ther. 2025 Nov 27;57(1):340-355. doi: 10.5114/ait/210612.ABSTRACTIntra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are now recognized as important but often underdiagnosed contributors to cardiovascular instability in critically ill patients. Recent s

H Hatem Soliman Aboumarie

Preventive Effect of Shenfu Injection on Arrhythmia After Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: A Prospective Randomized Controlled Trial

Cardiovasc Ther. 2025 Nov 30;2025:4097327. doi: 10.1155/cdr/4097327. eCollection 2025.ABSTRACTBACKGROUND AND AIMS: Arrhythmias and major adverse cardiac events remain significant complications following ST-segment elevation myocardial infarction (STEMI). Shenfu injection, a traditional Chinese medic

X Xiaohan Qiu

Recalibration of the Framingham coronary heart disease risk score for a selected Sri Lankan population and its association with carotid artery intima-media thickness: A cross-sectional study

JRSM Cardiovasc Dis. 2025 Dec 5;14:20480040251405685. doi: 10.1177/20480040251405685. eCollection 2025 Jan-Dec.ABSTRACTOBJECTIVE: Carotid artery intima-media thickness (CIMT) is a non-invasive marker of subclinical atherosclerosis and a predictor of coronary heart disease (CHD). This study aimed (1)

V Visula Abeysuriya

E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy

MedComm (2020). 2025 Dec 7;6(12):e70528. doi: 10.1002/mco2.70528. eCollection 2025 Dec.ABSTRACTE3 ubiquitin ligases are pivotal regulators within the ubiquitin-proteasome system, conferring specificity to protein ubiquitination and subsequent degradation, thereby maintaining cellular homeostasis. Th

H Haochen Wang

Amiloride: revisiting an old drug for resistant hypertension

Clin Hypertens. 2025 Dec 1;31:e42. doi: 10.5646/ch.2025.31.e42. eCollection 2025.ABSTRACTResistant hypertension (RH) remains a major clinical challenge, defined as uncontrolled blood pressure (BP) despite the use of 3 antihypertensive agents, including a renin-angiotensin system inhibitor, a calcium

C Chan Joo Lee